Global Health Ltd, the parent company of Medanta Hospitals, reported strong financial results for the quarter ended September 30, 2025, with both revenue and profit showing double-digit growth.
The company reported revenue of ₹11,189 million, reflecting a strong year-on-year (YoY) growth of 14.9%. Profit after tax (PAT) stood at ₹1,584 million, marking an impressive increase of 21.1% YoY, with the PAT margin improving to 14.2% from 13.4% in the previous year. EBITDA (excluding Noida) rose by 13.7% YoY to ₹2,804 million, achieving a margin of 25.2%, while EBITDA (including Noida) increased by 5.7% YoY to ₹2,607 million, with a margin of 23.3%.
The company launched a 550-bed Noida hospital in September 2025, contributing ₹ 39 million in revenue but incurring an initial loss of ₹197 million due to ramp-up costs. Operationally, occupied bed-days rose 7.7% , occupancy stood at 64% , and ARPOB improved 5.5% YoY to ₹65,570. Inpatient and outpatient volumes grew 12.7% and 14.9% , respectively.
Revenue from international patients increased 48.5% to ₹762 million and pharmacy business grew 23.9% to ₹456 million. By segment, developing hospitals saw revenue up 28.3% and EBITDA up 34%, while mature hospitals posted modest growth of 5.4% in revenue and 0.4% in EBITDA.
CEO Pankaj Sahni said the Noida facility expands Medanta’s reach and that strong growth across the network reflects the company’s focus on quality care and operational efficiency. Overall, Medanta delivered a solid quarter with robust revenue and profit growth, supported by rising patient volumes, higher realizations, and ongoing expansion in new markets.